Related Experiment Video
Updated: Mar 9, 2026

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
Published on: December 30, 2025
Negative auto-regulators trap p53 in their web
Xiang Zhou1, Bo Cao2, Hua Lu2
1Fudan University Shanghai Cancer Center and the Institutes of Biomedical Sciences, Fudan University, Shanghai 200032, China.
Abstract:
The transcriptional factor p53 activates the expression of a myriad of target genes involving a complicated signalling network, resulting in various cellular outcomes, such as growth arrest, senescence, apoptosis, and metabolic changes, and leading to consequent suppression of tumour growth and progression. Because of the profoundly adverse effect of p53 on growth and proliferation of cancer cells, several feedback mechanisms have been employed by the cells to constrain p53 activity. Two major antagonists MDM2 and MDMX (the long forms) are transcriptionally induced by p53, but in return block p53 activity, forming a negative feedback circuit and rendering chemoresistance of several cancer cells. However, they are not alone, as cancer cells also employ other proteins encoded by p53 target genes to inhibit p53 activity at transcriptional, translational, and posttranslational levels. This essay is thus composed to review a recent progress in understanding the mechanisms for how cancer cells hijack the p53 autoregulation by these proteins for their growth advantage and to discuss the clinical implications of these autoregulatory loops.
Insights
Cancer cells exploit feedback loops to suppress the tumor suppressor p53. Understanding these mechanisms, including MDM2 and MDMX, is key to developing new cancer therapies.
Area of Science:
- Molecular Biology
- Cancer Biology
- Genetics
Background:
- The tumor suppressor p53 regulates genes involved in cell cycle arrest, senescence, apoptosis, and metabolism, crucial for suppressing tumor growth.
- Cancer cells develop resistance to p53's tumor-suppressive functions through various feedback mechanisms.
- Key antagonists like MDM2 and MDMX are induced by p53 but inhibit its activity, forming negative feedback loops that promote cancer cell survival and chemoresistance.
Purpose of the Study:
- To review recent advancements in understanding how cancer cells manipulate p53 autoregulation for their benefit.
- To discuss the clinical implications of these p53 autoregulatory loops in cancer treatment.
Main Methods:
- Literature review of recent research on p53 autoregulation.
- Analysis of mechanisms used by cancer cells to inhibit p53 activity at multiple levels (transcriptional, translational, posttranslational).
Main Results:
- Cancer cells utilize proteins encoded by p53 target genes to constrain p53 activity.
- These hijacking mechanisms allow cancer cells to evade p53-mediated tumor suppression.
- The interplay between p53 and its antagonists contributes to cancer progression and chemoresistance.
Conclusions:
- Elucidating these autoregulatory loops provides insights into cancer cell survival strategies.
- Targeting these feedback mechanisms holds potential for novel cancer therapeutic interventions.
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
The Intrinsic Apoptotic Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

